Syncona Limited is an investment company with a focus on healthcare. Based in London, UK, it was established in 2012 as a subsidiary of the Wellcome Trust, an independent global charitable foundation. Syncona's mission is to unlock the potential of revolutionary science to transform the lives of patients with serious medical needs. It does this by partnering with leading scientists, entrepreneurs, and management teams, and providing long-term capital, strategic insight, and operational support. The company invests in and builds companies that explore cutting-edge technologies, such as gene therapy, cell therapy, and precision medicine. Its portfolio includes several successful businesses, such as Nightstar Therapeutics, Gyroscope Therapeutics, and Freeline Therapeutics, that are developing groundbreaking treatments for diseases such as blindness, hemophilia, and Parkinson's.Year founded
8 Bloomsbury Street, WC1B 3SR London – Guernsey
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.